While gain‐of‐function mutations in the ECD of RTKs (such as EGFR) have been reported, gain of function mutations in the RTK TKD are more prevalent in adult cancers (Lahiry et al, 2010; Medves & Demoulin, 2012; Bresler Scott et al, 2014). This evidence concerns the gene EGFR and cancer.